Cf. Turner et Ar. Sheon, BEHAVIORAL-STUDIES RELEVANT TO VACCINE TRIAL PREPARATION - AN INTRODUCTION, AIDS research and human retroviruses, 10, 1994, pp. 190000273-190000276
Preparations for large-scale trials to test the efficacy of candidate
HIV vaccines can benefit in several crucial ways from a targeted progr
am of behavioral and social research. Randomized field experiments tes
ting alternative procedures for the recruitment and retention of subje
cts can help identify research procedures that will ensure adequate sa
mple sizes while minimizing sample attrition over time. Similarly, ass
uring that subjects accurately comprehend the potential risks of parti
cipation will require more than simply presenting scientifically accur
ate information. Ensuring both the adequacy and appropriateness of ris
k communications as well as the accuracy of subject perception of risk
s (across the social and cultural milieux in which vaccine trials will
be undertaken) is a critical task. Ethnographic and behavioral studie
s can help to ensure that our obligation to obtain truly informed cons
ent from our research subjects is fully met and documented. Monitoring
risk behaviors over the course of the vaccine trials could also benef
it from strategic investments in new technologies developed by social
researchers to permit the collection of sensitive personal data while
affording complete privacy to subjects. These new measurement technolo
gies include procedures that permit private data collection (without a
human interviewer) in any spoken language and without requiring that
subjects be literate.